Document is current
Any future updates will be listed below
-
Authors
Perelman, Sofya S. https://orcid.org/0000-0001-9706-8156
James, David B. A.
Boguslawski, Kristina M.
Nelson, Chase W.
Ilmain, Juliana K. https://orcid.org/0000-0002-9507-5069
Zwack, Erin E.
Prescott, Rachel A.
Mohamed, Adil
Tam, Kayan
Chan, Rita
Narechania, Apurva
Pawline, Miranda B.
Vozhilla, Nikollaq
Moustafa, Ahmed M. https://orcid.org/0000-0002-9949-6936
Kim, Sang Y.
Dittmann, Meike
Ekiert, Damian C.
Bhabha, Gira
Shopsin, Bo
Planet, Paul J.
Koralov, Sergei B. https://orcid.org/0000-0002-4843-3791
Torres, Victor J. https://orcid.org/0000-0002-7126-0489
-
Funding
Funding for this research was provided by:
S.S.P. was supported by the Jan Vilcek/David Goldfarb Fellowship Endowment Funds and Bernard B. Levine Program for Postdoctoral Research Fellowships in Immunology.
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (F32AI122486, T32AI007180, T32 AI007180, T32AI007180, R01AI137336, R01AI140754, R01AI137526, R01AI099394, R01AI105129, HHSN272201400019C, R01AI137336, R01AI140754, R01AI121244)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM007308)
Vilcek MSTP Scholars award
Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History, and a Postdoctoral Research Fellowship from Academia Sinica.
V.J.T. is a Burroughs Wellcome Fund Investigator in the pathogenesis of infectious diseases
- License Information
-
More Information
Article History
Received: 8 May 2020
Accepted: 11 March 2021
First Online: 19 April 2021
Competing interests
: V.J.T. is an inventor on patents and patent applications filed by New York University, which are currently under commercial license to Janssen Biotech Inc. (patent nos. US10669329; US10202440; US10087243; MY-175062-A; BR112013032774-0; 60 2014 068 192.1; 40000719B; 1190640B9; 10-2050267; 2012273125; 2012273123; 10,781,246; 10,301,378; 9,783,597; 9,657,103; 9,644,023; 9,481,723; 9,480,726; 9,091,689; 8,846,609; 6758363; 6452765; 6,170,913; 6,093,760; 3441474; 3403669; 3011012; 2,720,754; 2720714; 2,635,462; 2,613,135; 2,609,650; 730359; 710,439; 619,942; 619,938; 357,938; 343,589; 340,446; and 229922). Janssen Biotech Inc. provides research funding and other payments associated with the licensing agreement. All other authors declare no conflicts of interest.
